Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study

BACKGROUND: Herpes zoster (HZ) and associated complications cause significant burden to older people. A HZ vaccination programme was introduced in Aotearoa New Zealand in April 2018 with a single dose vaccine for those aged 65 years and a four-year catch up for 66–80 year-olds. This study aimed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbinta, James F., Wang, Alex X., Nguyen, Binh P., Paynter, Janine, Awuni, Prosper Mandela A., Pine, Russell, Sporle, Andrew A., Simpson, Colin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985042/
https://www.ncbi.nlm.nih.gov/pubmed/36879782
http://dx.doi.org/10.1016/j.lanwpc.2022.100601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985042/
https://www.ncbi.nlm.nih.gov/pubmed/36879782
http://dx.doi.org/10.1016/j.lanwpc.2022.100601

Ejemplares similares